News FDA lends a hand to Novo, Lilly on illegal GLP-1 imports The FDA has set up a green list of overseas sources for GLP-1 ingredients to try to block imports of illegitimate and potentially unsafe materials.
News Massachusetts bucks HHS, issuing its own COVID guidelines The Bay State is the first to require insurers to cover the shot for everyone, despite conflicting guidance from RFK's HHS on who should get the jab.
News FDA releases previously unseen CRLs in transparency push The FDA's earlier decision to publish complete response letters was largely a repackaging of existing information, but now it has gone much further.
News RFK faces bipartisan pressure at fractious hearing In a three-hour hearing before the Finance Committee, Senators took RFK to task about CDC ousting and broken promises about the COVID-19 vaccine.
News Dismay as Florida seeks to end vaccination protections Florida's plan to become the first US state to end all vaccine mandates, including children's pre-school shots, is labelled 'reckless'.
News Medical groups, federal staffers call for RFK Jr to resign The call for HHS Secretary Kennedy to resign is fast becoming a clamour, as medical, public health and patient groups, and federal employees chime in.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.